Efficacy and Safety of Topical ALT-2074 (SYI-2074) for Treatment of Chronic Plaque Psoriasis

Trial Profile

Efficacy and Safety of Topical ALT-2074 (SYI-2074) for Treatment of Chronic Plaque Psoriasis

Discontinued
Phase of Trial: Phase II

Latest Information Update: 10 May 2014

At a glance

  • Drugs SYI 2074 (Primary)
  • Indications Plaque psoriasis
  • Focus Therapeutic Use
  • Sponsors Synvista Therapeutics
  • Most Recent Events

    • 10 May 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top